DLEU1 and neoplasm: To confirm the oncogenic functionality of DLEU1 in vivo, we performed mouse xenograft experiments, which showed that siRNA targeting DLEU1 significantly suppressed xenograft tumor formation by OSCC cells in nude mice (Fig. 4a, b).